Your browser doesn't support javascript.
loading
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.
Lee, Rebecca J; Wysocki, Oskar; Zhou, Cong; Shotton, Rohan; Tivey, Ann; Lever, Louise; Woodcock, Joshua; Albiges, Laurence; Angelakas, Angelos; Arnold, Dirk; Aung, Theingi; Banfill, Kathryn; Baxter, Mark; Barlesi, Fabrice; Bayle, Arnaud; Besse, Benjamin; Bhogal, Talvinder; Boyce, Hayley; Britton, Fiona; Calles, Antonio; Castelo-Branco, Luis; Copson, Ellen; Croitoru, Adina E; Dani, Sourbha S; Dickens, Elena; Eastlake, Leonie; Fitzpatrick, Paul; Foulon, Stephanie; Frederiksen, Henrik; Frost, Hannah; Ganatra, Sarju; Gennatas, Spyridon; Glenthøj, Andreas; Gomes, Fabio; Graham, Donna M; Hague, Christina; Harrington, Kevin; Harrison, Michelle; Horsley, Laura; Hoskins, Richard; Huddar, Prerana; Hudson, Zoe; Jakobsen, Lasse H; Joharatnam-Hogan, Nalinie; Khan, Sam; Khan, Umair T; Khan, Khurum; Massard, Christophe; Maynard, Alec; McKenzie, Hayley.
Afiliación
  • Lee RJ; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Wysocki O; The University of Manchester, Manchester, United Kingdom.
  • Zhou C; The University of Manchester, Manchester, United Kingdom.
  • Shotton R; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom.
  • Tivey A; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom.
  • Lever L; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Woodcock J; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Albiges L; The University of Manchester, Manchester, United Kingdom.
  • Angelakas A; The University of Manchester, Manchester, United Kingdom.
  • Arnold D; The University of Manchester, Manchester, United Kingdom.
  • Aung T; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Banfill K; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Baxter M; Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Hamburg, Germany.
  • Barlesi F; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Bayle A; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Besse B; The University of Manchester, Manchester, United Kingdom.
  • Bhogal T; Division of Molecular and Clinical Medicine, Ninewells School of Medicine, University of Dundee, Dundee, United Kingdom.
  • Boyce H; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Britton F; Aix Marseille University, CNRS, INSERM, CRCM, Marseille, France.
  • Calles A; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Castelo-Branco L; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Copson E; Drug Development Department (DITEP) Gustave Roussy-Cancer Campus, Villejuif, France.
  • Croitoru AE; The Clatterbridge Cancer Center NHS Foundation Trust, Liverpool, United Kingdom.
  • Dani SS; Weston Park Cancer Center, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Dickens E; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Eastlake L; Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Fitzpatrick P; ESMO-CoCARE Steering Committee, European Society for Medical Oncology, Lugano, Switzerland.
  • Foulon S; NOVA National School of Public Health, Lisboa, Portugal.
  • Frederiksen H; Department of Medical Oncology, University Hospital Center of Algarve, Faro, Portugal.
  • Frost H; Cancer Sciences Academic Unit, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Ganatra S; Medical Oncology Department, Fundeni Clinical Institute, Bucuresti, Romania.
  • Gennatas S; Lahey Hospital and Medical Center, Burlington, MA.
  • Glenthøj A; Oncology Department, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.
  • Gomes F; University Hospitals Plymouth NHS Trust, Crownhill, Plymouth, Devon, United Kingdom.
  • Graham DM; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom.
  • Hague C; Oncostat U1018, Inserm, Paris-Saclay University, Labeled Ligue Contre le Cancer, Villejuif, France.
  • Harrington K; Biostatistics and Epidemiology Office, Gustave Roussy, University Paris-Saclay, Villejuif, France.
  • Harrison M; Department of Haematology, Odense University Hospital, Odense, Denmark.
  • Horsley L; Cancer Research UK Manchester Institute Cancer Biomarker Center, The University of Manchester, Alderley Park, United Kingdom.
  • Hoskins R; Lahey Hospital and Medical Center, Burlington, MA.
  • Huddar P; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Hudson Z; Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Jakobsen LH; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Joharatnam-Hogan N; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Khan S; The University of Manchester, Manchester, United Kingdom.
  • Khan UT; The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Khan K; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Massard C; The Institute of Cancer Research NIHR Biomedical Research Center, London, United Kingdom.
  • Maynard A; Ninewells Hospital and Medical School, Dundee, United Kingdom.
  • McKenzie H; The Christie NHS Foundation Trust, Manchester, United Kingdom.
JCO Clin Cancer Inform ; 6: e2100177, 2022 05.
Article en En | MEDLINE | ID: mdl-35609228
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Clin Cancer Inform Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JCO Clin Cancer Inform Año: 2022 Tipo del documento: Article